DelMar Pharmaceuticals Inc Share Price Nasdaq
Equities
US2470782077
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 6.82M 544M |
---|---|---|---|---|---|
Net income 2022 | -22M -1.75B | Net income 2023 | -14M -1.12B | EV / Sales 2022 | - |
Net cash position 2022 | 11.78M 940M | Net cash position 2023 | 2.61M 208M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.54
x | P/E ratio 2023 |
-0.43
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.81% |
Latest transcript on DelMar Pharmaceuticals Inc
Managers | Title | Age | Since |
---|---|---|---|
Robert Hoffman
CEO | Chief Executive Officer | 58 | 10/04/18 |
Greg Johnson
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Hoffman
CEO | Chief Executive Officer | 58 | 10/04/18 |
Tamara Favorito
BRD | Director/Board Member | 65 | 28/04/21 |
Laura Douglass
BRD | Director/Board Member | 59 | 25/06/20 |
1st Jan change | Capi. | |
---|---|---|
-2.58% | 103B | |
+1.37% | 95.28B | |
+1.75% | 22.15B | |
-15.67% | 21.02B | |
-8.19% | 18.15B | |
-41.01% | 16.73B | |
-13.43% | 16.05B | |
+4.04% | 13.68B | |
+34.55% | 12.17B |